@kshansenMDi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
@CU_Transplant Surgeon | @UCSFSurgery Alum | @SUBiodesign Innovator | @DiatiroCo Founder
San Francisco, CA
Joined November 2015
- Tweets172
- Following543
- Followers283
- Likes1.2K
Keith Hansen, MD retweeted
Back from #ATC26, kicking off Day 1 of our SORT Symposium! Amazed by the interest in robotic solid organ transplant. Humbled to have true leaders in the field with us — excited to learn from each other and make new connections. #SORT2026 #ATC2026
@CleClinicUro
That’s a wrap on #atc2026Boston. This moment of zen has been brought to you by KidneyPod and the team at @DiatiroHealth.
Surgeons - thanks for filling out our survey at KidneyPod.com and sharing how you keep your cool.
One early theme from #ATC2026Boston conversations:
There is no single “standard” way surgeons manage the kidney between ice and reperfusion.
The workflow changes by surgeon, center, anatomy, exposure, donor quality, open vs robotic approach, and how long the anastomosis takes
That variability is exactly why we’re asking transplant surgeons to complete the KidneyPod practice survey at #atc2026Boston
Before asking the field to change, we need to understand what the field is already doing.
Survey: KidneyPod.com
Booth 339 at ATC
#ATC2026Boston
ATC starts today.
The kidney leaves ice before it receives blood.
We’re asking kidney transplant surgeons how they manage that interval today.
If you transplant kidneys, please take 3 minutes:
KidneyPod.com
Or visit Diatiro at Booth 339.
#ATC2026Boston
The kidney leaves ice before it receives blood.
We’re asking kidney transplant surgeons how they manage that interval today.
Survey: KidneyPod.com
Booth 339
Investigational device. Not FDA-cleared. Not available for sale.
Keith Hansen, MD retweeted
Robotic kidney transplantation is at the forefront of transplant surgery innovation. As adoption grows, transplant programs are evaluating how this minimally invasive approach may improve outcomes, expand access, and enhance patient care. brnw.ch/21x3o2N
Keith Hansen, MD retweeted
To everyone who visited us at #WTC2025—thank you. The KidneyPod was built with your feedback, and this is just the beginning. Let’s stay connected as we look ahead. #TransplantSurgery
Keith Hansen, MD retweeted
KidneyPod is here! Surgeons from across the globe are stopping by the World Transplant Congress Booth 200 to see the KidneyPod up close. The interest, questions, and ideas have been incredible. Thank you for the early energy at #WTC2025. #TransplantSurgery
Keith Hansen, MD retweeted
Another great interview from Booth #821 at #WTC2025! We’re joined by Keith Hansen of @DiatiroHealth to discuss innovation in transplant technology and how the Kidney Pod is helping preserve donor organs in the moments that matter most.
Stop by to meet the team, explore our case studies, and test your skills with our life-sized Operation game!
Diatiro is here at WTC, booth # 200.
diatirohealth.com/home
#OrganDonation #KidneyHealth #WTC2025 #Nephrology #KidneyPod
4 years of work.
3 surgeon–engineer design sprints.
200+ prototypes.
1 FDA Breakthrough Designation.
T-12 days until our reveal.
@nkf @ASTSChimera @ATCMeeting @UCSFTransplant @StanfordAbdTxp @CU_Transplant
Keith Hansen, MD retweeted
At Diatiro we asked: What if we could protect the organ until the last stitch? We’ll share our answer in August at World Transplant Congress. Stay tuned.
KidneyPod™ has received Breakthrough Device Designation. It has not been cleared by the FDA for commercial use. #wtc2025